版本:
中国

BRIEF-Avinger announces verified data of 24-month outcomes from pivotal vision study of Lumivascular technology

May 31 Avinger Inc :

* Avinger announces verified data of 24-month outcomes from the pivotal vision study of Lumivascular technology for Peripheral Artery Disease

* Announced positive two-year clinical data from pivotal vision study of company's Lumivascular technology Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐